Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

被引：0
|
作者：
Nieves Martinez Chanza
Louisa Soukane
Philippe Barthelemy
Aurélien Carnot
Thierry Gil
Vinciane Casert
Vincent Vanhaudenarde
Brieuc Sautois
Lionel Staudacher
Jan Van den Brande
Stephane Culine
Emmanuel Seront
Marco Gizzi
Simone Albisinni
Thibault Tricard
Jean Christophe Fantoni
Marianne Paesmans
Rafael Caparica
Thierry Roumeguere
Ahmad Awada
机构：
[1] Jules Bordet Institute,Hopital Erasme
[2] Université Libre de Bruxelles,Clinique Sainte
[3] Université Libre de Bruxelles,Elisabeth
[4] Institut de Cancérologie Strasbourg Europe ICANS,undefined
[5] Centre Oscar Lambret,undefined
[6] Centre Hospitalier Universitaire de Ambrois Paré,undefined
[7] UCL,undefined
[8] University Hospital of Liege (CHU Sart Tilman),undefined
[9] Hopital Paris Saint Joseph,undefined
[10] University Hospital Antwerp,undefined
[11] UZA,undefined
[12] Hopital Saint-Louis,undefined
[13] Hopital de Jolimont,undefined
[14] Grand Hopital de Charleroi,undefined
来源：
BMC Cancer | / 21卷
关键词：
Avelumab; Bladder cancer; Checkpoint inhibitor; Immunotherapy; Neoadjuvant; PD-1 blockade; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] DUTRENEO Trial: A phase II randomized trial of DUrvalumab and TREmelimumab as NEOadjuvant approach in muscle-invasive urothelial bladder cancer (MIBC) patients prospectively selected by immune signature scores.
    Grande, Enrique
    Guerrero, Felix
    Puente, Javier
    Galante, Isabel
    Duran, Ignacio
    Fuentes, Javier
    Alonso-Gordoa, Teresa
    Burgos, Javier
    Font Pous, Albert
    Buisan, Oscar
    Pinto, Alvaro
    Alvarez-Maestro, Mario
    Reig Torras, Oscar
    Maroto, Pablo
    Garcia del Muro, Xavier
    Galvan, Patricia
    Malats, Nuria
    Prat, Aleix
    Real, Francisco X.
    Castellano, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] RANDOMIZED PHASE II TRIAL WITH AN UPA INHIBITOR (WX-671) IN PATIENTS WITH LOCALLY ADVANCED NON-METASTATIC PANCREATIC CANCER
    Heinemann, V.
    Ebert, M.
    Pinter, T.
    Mala, C.
    Neville, N.
    Bevan, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 226 - 226
  • [33] PHASE II TRIAL OF NEOADJUVANT AXITINIB IN PATIENTS WITH LOCALLY ADVANCED NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA
    Karam, Jose
    Devine, Catherine
    Urbauer, Diana
    Lozano, Marisa
    Maity, Tapati
    Ahrar, Kamran
    Tamboli, Pheroze
    Tannir, Nizar
    Wood, Christopher
    JOURNAL OF UROLOGY, 2014, 191 (04): : E646 - E646
  • [34] Impact of non-muscle invasive bladder cancer treatment history on the efficacy of pembrolizumab for patients with metastatic urothelial carcinoma
    Taoka, R.
    Kobayashi, T.
    Hidaka, Y.
    Abe, H.
    Morita, S.
    Ogawa, O.
    Nishiyama, H.
    Kitamura, H.
    Sugimoto, M.
    EUROPEAN UROLOGY, 2022, 81 : S1340 - S1341
  • [35] Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial
    Calcagno, Fabien
    Mouillet, Guillaume
    Adotevi, Olivier
    Maurina, Tristan
    Nguyen, Thierry
    Montcuquet, Philippe
    Curtit, E.
    Kleinclauss, F.
    Pivot, Xavier
    Borg, Christophe
    Thiery-Vuillemin, Antoine
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [36] Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial
    Fabien Calcagno
    Guillaume Mouillet
    Olivier Adotevi
    Tristan Maurina
    Thierry Nguyen
    Philippe Montcuquet
    E. Curtit
    F. Kleinclauss
    Xavier Pivot
    Christophe Borg
    Antoine Thiery-Vuillemin
    Medical Oncology, 2016, 33
  • [37] Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients
    Seitz, JF
    Bennouna, J
    Paillot, B
    Gamelin, E
    François, E
    Conroy, T
    Raoul, JL
    Becouarn, Y
    Bertheault-Cvitkovic, F
    Ychou, M
    Nasca, S
    Fandi, A
    Barthelemy, P
    Douillard, JY
    ANNALS OF ONCOLOGY, 2002, 13 (07) : 1072 - 1079
  • [38] A RETROSPECTIVE REVIEW OF RADIATION THERAPY IN NON-METASTATIC MUSCLE-INVASIVE BLADDER CANCER AT A TERTIARY CARE UNIVERSITY HOSPITAL IN PAKISTAN
    Hina, Mariam
    Ali, Nasir
    Abbasi, Ahmed Nadeem
    Khan, Agha Muhammad Hammad
    Lakhani, Sohail
    Mansha, Muhammad Atif
    Tariq, Maria
    Abrar, Sehrish
    Hafiz, Asim
    Qureshi, Bilal Mazhar
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S69 - S69
  • [39] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine plus Cisplatin in Patients with Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2020, 203 (04): : 659 - 660
  • [40] Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer
    Voskuilen, Charlotte S.
    van der Heijden, Michiel S.
    van Rhijn, Basw. G.
    EUROPEAN UROLOGY, 2019, 76 (06) : 870 - 871
12345